收录解读
Robin 把文献检索 agent、假设生成、实验建议、数据分析和结果解释连接成 lab-in-the-loop 的科学发现系统，而不是只做单点文献问答或代码生成。
论文在干性年龄相关性黄斑变性场景中验证了系统：Robin 提出增强 RPE 吞噬作用的治疗策略，识别并体外确认 ripasudil 与 KL001，并进一步提出和分析 RNA-seq 实验以解释机制。
它值得正式收录，因为 Nature 顶刊论文给出了 AI agent 直接参与真实实验生物学发现闭环的强证据，属于自动化科学发现从 workflow demo 进入实证发现的关键节点。
它没有更高，是因为系统仍依赖人类实验执行与问题设定，跨疾病、跨实验平台和长期自主可靠性还需要更多独立验证。
原始摘要与中文对照
中文对照翻译
科学发现是由观察、假设生成、实验和数据分析的迭代过程驱动的。尽管人工智能在生物学应用方面取得了最新进展，但目前还没有系统能够自动化所有这些阶段 [1, 2, 3]。在本文中，我们介绍了Robin，这是第一个能够完全自动化实验生物学中假设生成和数据分析的多智能体系统。通过将文献检索智能体与数据分析智能体相结合，Robin能够生成假设、提出实验、解释实验结果并生成更新的假设，从而实现一种半自主的科学发现方法。通过应用该系统，我们成功地为干性年龄相关性黄斑变性 (dAMD) 确定了有前景的治疗候选药物，dAMD是发达国家致盲的主要原因 [4, 5]。Robin提出增强视网膜色素上皮细胞吞噬作用作为一种治疗策略，并确定并证实了ripasudil和KL001的体外疗效。Ripasudil是一种临床上使用的Rho激酶 (ROCK) 抑制剂，此前从未被提议用于治疗dAMD。为了阐明ripasudil诱导吞噬作用上调的机制，Robin随后提出并分析了一项后续的RNA测序实验，该实验揭示了脂质外排泵和可能的全新靶点ABCA1的上调。本报告正文中的所有假设、实验方向、数据分析和数据图表均由Robin生成。作为第一个在迭代的实验室循环框架内自主发现和验证新型治疗候选药物的AI系统，Robin为AI驱动的科学发现建立了新范式。
原始摘要
Scientific discovery is driven by the iterative process of observation, hypothesis generation, experimentation, and data analysis. Despite recent advancements in applying artificial intelligence to biology, no system has yet automated all these stages [1, 2, 3]. Here, we introduce Robin, the first multi-agent system capable of fully automating both hypothesis generation and data analysis for experimental biology. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret experimental results, and generate updated hypotheses, achieving a semi-autonomous approach to scientific discovery. By applying this system, we were able to identify promising therapeutic candidates for dry age-related macular degeneration (dAMD), the major cause of blindness in the developed world [4, 5]. Robin proposed enhancing retinal pigment epithelium phagocytosis as a therapeutic strategy, and identified and confirmed in vitro efficacy for ripasudil and KL001. Ripasudil is a clinically-used Rho kinase (ROCK) inhibitor that has never previously been proposed for treating dAMD. To elucidate the mechanism of ripasudil-induced upregulation of phagocytosis, Robin then proposed and analyzed a follow-up RNA-seq experiment, which revealed upregulation of ABCA1 , a lipid efflux pump and possible novel target. All hypotheses, experimental directions, data analyses, and data figures in the main text of this report were produced by Robin. As the first AI system to autonomously discover and validate novel therapeutic candidates within an iterative lab-in-the-loop framework, Robin establishes a new paradigm for AI-driven scientific discovery.